PhD Scientific Days 2026

Poster Session 3.J - Theoretical and Translational Medicine

In silico investigation of photoactivatable VEGFR2 inhibitor EYE1118 for targeted therapy of retinal neovascular diseases

Name of the presenter

Szappanos, Attila

Institute/workplace of the presenter

Institute of Clinical Pathophysiology

Authors

Attila Szappanos¹, Balázs Besztercei¹, Réka Antal¹, Dr. Krisztián András Kovács¹

1: Institute of Clinical Pathophysiology